The audiologist and researcher will help accelerate the company’s clinical research in aural rehabilitation.
Neurotone AI announced that audiology researcher Brian Taylor, AuD, has joined the company as vice president of clinical research and professional relations. In his new role, Dr Taylor will help accelerate the company’s clinical research, support new studies, and help providers integrate brain-based hearing care into their treatment plans.
“Aural rehabilitation is clearly turning a corner. After decades in audiology, I’ve never been more excited about the potential of a technology to transform how we help patients hear and communicate. After meeting the team and taking a deeper look at the work Neurotone AI is doing, I’m convinced this approach represents the future of hearing care,” says Dr Taylor, in a release.
With nearly three decades in audiology, Dr Taylor previously served as senior director of audiology at Signia. He is the editor of Audiology Practices, a quarterly journal of the Academy of Doctors of Audiology, editor-at-large for Hearing Health and Technology Matters, and an adjunct instructor at the University of Wisconsin. Dr Taylor is also the author of several textbooks, including Audiology Practice Management.
“We feel incredibly fortunate that Brian is joining the Neurotone AI team. Brian is one of the most respected voices in audiology, with decades of experience in research, clinical care, and practice management. Brian understands both the science and the business of hearing care, and that perspective will help us continue raising the standard for hearing care,” says Rick Carlson, co-founder and CEO of Neurotone AI, in a release.
Carlson added that Dr Taylor’s decision to join the company reflects the growing momentum behind aural rehabilitation as a core component of hearing healthcare. Earlier in his career, Taylor contributed to clinical research on the original LACE program, which the company’s Lace AI Pro builds upon.
